BillionToOne, Inc. (BLLN) vs LivaNova PLC (LIVN)
A side-by-side comparison of BillionToOne, Inc. and LivaNova PLC across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLLN
BillionToOne, Inc.
$99.08HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
LIVN
LivaNova PLC
$75.60HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
Total return — BLLN vs LIVN
growth of $100 · dividends reinvested · last 1yBLLN +0.1% (+0.1%/yr)LIVN +41.7% (+41.7%/yr)LIVN compounded faster over this window
BLLN LIVN
BLLN vs LIVN: by the numbers
- •BLLN is the larger company ($4.56B vs $4.15B market cap).
- •LIVN trades at the lower trailing earnings multiple (22.30 vs 159.78 P/E), one valuation lens rather than an overall verdict.
- •LIVN converts more revenue to profit (12.82% vs 8.43% net margin).
Metrics side by side
Valuation
| Metric | BLLN | LIVN |
|---|---|---|
| P/E ratio | 159.78 | 22.30 |
| Forward P/E | 124.74 | 17.36 |
| P/S ratio | 11.47 | 2.82 |
| P/B ratio | 8.49 | 3.13 |
| EV / EBITDA | 74.69 | 16.32 |
| FCF yield | 0.73% | 3.57% |
Profitability
| Metric | BLLN | LIVN |
|---|---|---|
| Gross margin | 71.27% | 68.18% |
| Operating margin | 10.90% | 13.48% |
| Net margin | 8.43% | 12.82% |
| ROE | 6.24% | 14.23% |
| ROIC | 6.39% | 10.24% |
Growth (annualized)
| Metric | BLLN | LIVN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.57% |
| FCF CAGR (5Y) | N/A | 20.23% |
| Total return CAGR (5Y) | N/A | -1.66% |
Frequently asked
- Which has the lower trailing P/E, BLLN or LIVN?
- LIVN has the lower trailing P/E: BLLN trades at 159.78 and LIVN at 22.30. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Is BLLN or LIVN more profitable?
- LIVN runs the higher net margin — BLLN at 8.43% versus LIVN at 12.82%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.